Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 4, 2018

Primary Completion Date

August 17, 2019

Study Completion Date

January 7, 2020

Conditions

Overweight

Interventions

DIETARY_SUPPLEMENT

LMT1-48

capsules containing Probiotics

DIETARY_SUPPLEMENT

Placebo

capsules that did not contain any probiotics

Trial Locations (1)

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors

lead

Medy-Tox

INDUSTRY

NCT03759743 - Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject | Biotech Hunter | Biotech Hunter